Skip to main content
Log in

Factors Associated with HIV Status Disclosure in HIV-Infected Sub-Saharan Migrants Living in France and Successfully Treated with Antiretroviral Therapy: Results from the ANRS-VIHVO Study

  • Original Paper
  • Published:
Journal of Immigrant and Minority Health Aims and scope Submit manuscript

Abstract

To estimate rates and identify correlates of HIV disclosure in migrants from sub-Saharan Africa (SSA) successfully treated, a sub-analysis was conducted in HIV-1 native SSA migrants, living in France with undetectable viral load on antiretroviral, included in the VIHVO adherence study. Logistic regression models assessed factors associated with HIV disclosure. Among 246 individuals (40 % male, median age 41), 79 % of those in a steady heterosexual partnership (n = 167) had disclosed their status to their partner, 55 % of the total 246 to a relative, and 33 % to (an)other person(s). Disclosure to one’s steady partner was associated with a follow-up duration since HIV diagnosis of more than 5 years, a higher literacy level, a better social context and marital status. Women were more likely to disclose their HIV status to relatives. Interventions targeting this population should be provided to improve disclosure which in turn ensures better social support, testing of the partner and lower rates of undiagnosed HIV.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kippax SC, Aggleton P, Moatti JP, Delfraissy JF. Living with HIV: recent research from France and the French Caribbean (VESPA study), Australia, Canada and the United Kingdom. AIDS. 2007;21:S1–3.

    Article  PubMed  Google Scholar 

  2. Obermeyer CM, Baijal P, Pegurri E. Facilitating HIV disclosure across diverse settings: a review. Am J Public Health. 2011;101(6):1011–23.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Préau M, Marcellin F, Carrieri MP, Lert F, Obadia Y, Spire B, the VESPA Study Group. Health-related quality of life in French people living with HIV in 2003: results from the national ANRS-EN12-VESPA Study. AIDS. 2007;21:S19–27.

    Article  PubMed  Google Scholar 

  4. Bouillon K, Lert F, Sitta R, Schmaus A, Spire B, Dray-Spira R. Factors correlated with disclosure of HIV infection in the French Antilles and French Guiana: results from the ANRS-EN13-VESPA-DFA Study. AIDS. 2007;21:S89–94.

    Article  PubMed  Google Scholar 

  5. Cazein F, Pillonel J, Le Strat Y, Pinget R, Le Vu S, Brunet S, et al. Découvertes de séropositivité VIH et de SIDA, France, 2003–2013. Bull Epidémoil Hebd. 2015; (9–10):152–61. http://www.invs.sante.fr/beh/2015/9-10/2015_9-10_1.html.

  6. Bouvier G. Vue d’ensemble—Les descendants d’immigrés plus nombreux que les immigrés: une position française originale en Europe, 2010; INSEE. http://www.insee.fr/fr/ffc/docs_ffc/ref/IMMFRA12_b_VE_posfra.pdf.

  7. Lot F, Pillonel J, Pinget R, Cazein F, Bernillon P, Leclerc M, et al. Les pathologies inaugurales de sida, France, 2003–2010. Bull Epidémoil Hebd. 2011;43–44:454–8.

    Google Scholar 

  8. Abgrall S, Fugon L, Lélé N, Carde E, Bentata M, Patey O, Khuong MA, Spire B, Carrieri P, Bouchaud O. Visiting One’s Native Country: the Risks of Nonadherence in HIV-Infected Sub-Saharan Migrants—ANRS VIHVO Study. J Int Assoc Provid AIDS Care. 2013;12(6):407–13.

    Article  PubMed  Google Scholar 

  9. Yéni P, et le groupe d’experts sur l’infection à VIH. Prise en charge médicale des personnes infectées par le VIH. 2006. Traitement antiretroviral. Paris: Flammarion medicine-sciences 2006. p. 22–44. http://www.sante.gouv.fr/IMG/pdf/rapport-experts-2006/pdf.

  10. Hammer SM, Saag MS, Schechter M, Montaner JS, Schooley RT, Jacobsen DM, Thompson MA, Carpenter CC, Fischl MA, Gazzard BG, Gatell JM, Hirsch MS, Katzenstein DA, Richman DD, Vella S, Yeni PG, Volberding PA. International AIDS Society-USA panel. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel. JAMA. 2006;296(7):827–43.

    Article  CAS  PubMed  Google Scholar 

  11. Elford J, Ibrahim F, Bukutu C, Anderson J. Disclosure of HIV status: the role of ethnicity among people living with HIV in London. J Acquir Immune Defic Syndr. 2008;47:514–21.

    Article  PubMed  Google Scholar 

  12. Deribe K, Woldemichael K, Wondafrash M, Haile A, Amberbir A. Disclosure experience and associated factors among HIV positive men and women clinical service users in southwest Ethiopia. BMC Public Health. 2008;8:81.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Suzan-Monti M, Blanche J, Bilé P, Koulla-Shiro S, Abu-Zaineh M, Marcellin F, Boyer S, Carrieri MP, Spire B. Individual and structural factors associated with HIV Status disclosure to main partner in Cameroon: aNRS 12-116 EVAL Survey, 2006–2007. J Acquir Immune Defic Syndr. 2011;57:S22–6.

    Article  PubMed  Google Scholar 

  14. Issiaka S, Cartoux M, Ky-Zerbo O, Tiendrebeogo S, Meda N, Dabis F, et al. Living with HIV: women’s experience in Burkina Faso, West Africa. AIDS Care. 2001;3:123–8.

    Article  Google Scholar 

  15. Skogmar S, Shakely D, Lans M, Danell J, Andersson R, Tshandu N, Ode’n A, Francois Venter WD, Roberts S. Effect of antiretroviral treatment and counseling on disclosure of HIV-serostatus in Johannesburg, South Africa. AIDS Care. 2006;18:725–30.

    Article  CAS  PubMed  Google Scholar 

  16. Niccolai LM, King E, D’entremont D, Pritchett EN. Disclosure of HIV serostatus to sex partners: a new approach to measurement. Sex Transm Dis. 2006;33:102–5.

    Article  PubMed  Google Scholar 

  17. Makin JD, Forsyth BW, Visser MJ, Sikkema KJ, Neufeld S, Jeffery B. Factors affecting disclosure in South African HIV-positive pregnant women. AIDS Patient Care STDS. 2008;22(11):907–16.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Kumar A, Waterman I, Kumari G, Carter AO. Prevalence and correlates of HIV serostatus disclosure: a prospective study among HIV-infected postparturient women in Barbados. AIDS Patient Care STDS. 2006;20(10):724–30.

    Article  PubMed  Google Scholar 

  19. Bachanas P, Medley A, Pals S, Kidder D, et al. Disclosure, knowledge of partner status, and condom use among HIV-positive patients attending clinical care in Tanzania, Kenya, and Namibia. AIDS Patient Care STDS. 2013;27(7):425–35.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Olley BO, Seedat S, Gxamza F, Reuter H, Stein DJ. Self-disclosure of HIV serostatus in recently diagnosed patients with HIV in South Africa. Afr J Reprod Health. 2004;8(2):71–6.

    Article  CAS  PubMed  Google Scholar 

  21. Weinhardt LS, Kelly JA, Brondino MJ, Rotheram-Borus MJ, Kirshenbaum SB, Chesney MA, Remien RH, et al. HIV transmission risk behavior among men and women living with HIV in 4 cities in the United States. J Acquir Immune Defic Syndr. 2004;36(5):1057–66.

    Article  PubMed  Google Scholar 

  22. Dray-Spira R, Lert F, the VESPA Study Group. Living and working with HIV in France in results from the ANRS-EN12-VESPA Study. AIDS. 2003;2007(S1):S29–36.

    Google Scholar 

  23. Suzan-Monti M, Kouanfack C, Boyer S, Blanche J, Bonono RC, Delaporte E, Carrieri PM, Moatti JP, Laurent C, Spire B, Stratall ANRS 12-110/ESTHER Study Group. Impact of HIV comprehensive care and treatment on serostatus disclosure among cameroonian patients in Rural District Hospitals. PLoS One. 2013;8:1–9.

    Article  Google Scholar 

  24. Kalichman SC, Dimarco M, Austin J, Luke W, Difonzo K. Stress, social support, and HIV-status disclosure to family and friends among HIV-positive men and women. J Behav Med. 2003;26(4):315–32.

    Article  PubMed  Google Scholar 

  25. Peretti-Watel P, Spire B, Pierret J, Lert F, Obadia Y, VESPA Group. Management of HIV-related stigma and adherence to HAART: evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA 2003). AIDS Care. 2006;18(3):254–61.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We gratefully acknowledge the contributions of all clinical investigators of the VIHVO study: Michele Bentata (CHU Avicenne, Bobigny, France); Bruno Fantin (CHU Beaujon, Clichy, France); Cécile Goujard (CHU Bicêtre, Le Kremlin-Bicêtre, France); Sophie Matheron (CHU Bichat, Paris, France); Odile Launay (CHU Cochin, Paris, France); Vincent Le Moing (CHU de Montpellier, Montpellier, France); Olivier Lortholary (CHU Necker, Paris, France); Paul- Henri Consigny (CHU Pasteur, Paris, France); Matthieu Saada (Hôpital de Perpignan, Perpignan, France); Christine Katlama, Anne Simon (CHU Pitié-Salpétrière, Paris, France); Cédric Arvieux (CHU de Rennes, Rennes, France); Pauline Campa, Pierre-Marie Girard (CHU Saint-Antoine, Paris, France); Marie-Aude Khuong (Hôpital De Lafontaine, Saint- Denis, France); Jean-Michel Molina, Caroline Lascoux-Combe (CHU Saint-Louis, Paris, France); David Rey, Murielle Rondeau (Hôpital Civil, Strasbourg, France); Gilles Pialoux (CHU Tenon, Paris, France); Carine Couzigou, Daniel Vittecoq (CHU Paul Brousse, Villejuif, France); Olivier Patey (Hôpital de Villeneuve Saint Georges, Villeneuve saint Georges, France); Denis Malvy, Thierry Pistone, Philippe Morlat (CHU Bordeaux, Bordeaux, France); Michel Duong, Pascal Chavanet (CHU Dijon, Dijon, France). The authors thank Jude Sweeney for the revising and editing of the English version of this manuscript.

Funding

ANRS (France Recherche Nord&Sud Sida-hiv Hépatites) and the Sidaction

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to S. Abgrall.

Ethics declarations

Conflict of interest

No conflict of interest.

Ethical Standard

This study was approved by the institutional ethics committees, Direction Générale de la Santé and Comité de Protection des Personnes de la Pitié-Salpétrière, at the session of 26/04/2006. All individuals received written information, provided signed consent to participate in the cohort study and were informed of their right to prevent their personal data from being used.

Additional information

Clinical investigators of the study are listed in the Acknowledgments section.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 15 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kankou, J.M., Bouchaud, O., Lele, N. et al. Factors Associated with HIV Status Disclosure in HIV-Infected Sub-Saharan Migrants Living in France and Successfully Treated with Antiretroviral Therapy: Results from the ANRS-VIHVO Study. J Immigrant Minority Health 19, 843–850 (2017). https://doi.org/10.1007/s10903-016-0423-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10903-016-0423-1

Keywords

Navigation